Campus Berlin Buch (CBB)

Details Associates
Medical Suppliers In Berlin

Name :

Campus Berlin Buch (CBB)

Address  :

ECRC Experimental and Clinical Research Center
Lindenberger Weg 80

Town  :

Berlin

State  :

Berlin

Country  :

GERMANY

Post Code:

13125

Phone  :

49 30 450 50

Web URL  :

Available
Specialization
  • Oncologist
Facilities

Total Number Of Beds : 5000

Description
At the Campus BerlinBuch in northeast Berlin the Chariteacute Universitaumltsmedizin Berlin enjoys a partnership with the clinical and research institutions who specialize in basic research and comprehensive clinical care as well as with several biotechnology companies

For more than 100 years BerlinBuch has served as a key location for health care and research Between 1900 and 1920 hospitals with more than 5000 patient beds were constructed in BerlinBuch including the largest hospital in Europe at the time The clinical environment attracted scientific institutes and in 1930 the KaiserWilhelmInstitute for Brain Research moved to Buch Later the GDRs Academy of Sciences continued the biomedical research tradition here

Today the Campus BerlinBuch comprised of Specialized Clinics for Cancer and Cardiovascular Disease the Max Delbruumlck Center for Molecular Medicine MDC BerlinBuch the LeibnizInstitut fuumlr Molekulare Pharmakologie FMP as well as the biotechnology park with circa 50 companies is one of the largest biomedical centres in Germany In addition further hospitals and clinics call Buch home such as the Protestant Lung Clinic Berlin Evangelische Lungenklinik Berlin and the Rheuma Clinic BerlinBuch
NEWS
Ambulance staff can speed up stroke treatment

Treating stroke in specialised ambulances en route to hospital is feasible and could boost the number of patients who receive lifesaving therapy experts believe Mobile stroke units can halve the time it takes a patient to get clotbusting drugs a small German trial found The drugs only work if given within four and a half hours of stroke onset... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More